Introduction
Diseases associated with the TLR signaling cascade ↗ Stable identifier: R-HSA-5602358
Diseases: primary immunodeficiency disease Toll like receptors (TLRs) are sensors of the innate immune system that detect danger signals derived from pathogens (pathogen-associated molecular patterns -PAMP) or damaged cells (damage-associated molecular patterns -DAMP) (Pasare C and Medzhitov R 2005; Barton GM and Kagan JC 2009; Kawai T and Akira S 2010) . Signaling by these sensors promotes the activation and nuclear translocation of transcription factors (IRFs, NFkB and AP1). The transcription factors induce secretion of inflammatory cytokines such as IL-6, TNF and pro-IL1beta that direct the adaptive immune response. Inherited or acquired abnormalities in TLR-mediated processes may lead to increased susceptibility to infection, excessive inflammation, autoimmunity and malignancy (Picard C et al. 2010; Netea MG et al. 2012; Varettoni M et al. 2013 ). Here we describe four primary immunodeficiency (PID) disorders associated with defective TLRmediated responses. First, MyD88 or IRAK4 deficiency is characterized with a greater susceptibility to pyogenic bacteria in affected patients (Picard C et al. 2003; von Bernuth H et al. 2008) . Second, defects in the TLR3 signaling pathway are associated with a greater susceptibility to herpes simplex virus encephalitis (Zhang SY et al. 2013) . Third, imunodeficiencies due to defects in NFkB signaling components are linked to impaired TLR-mediated responses (Courtois G et al. 2003; Fusco F et al. 2004) . Finally, events are annotated showing constitutive activation of a somatically mutated MyD88 gene which results in malignancy (Varettoni M et al. 2013 ).
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Puel, A., Yang, K., Ku, CL., von Bernuth, H., Bustamante, J., Santos, OF. et al. (2005) . Heritable defects of the human TLR signalling pathways. J. Endotoxin Res., 11, 220-4. ↗ Picard, C., Casanova, JL., Puel, A. (2011) . Infectious diseases in patients with IRAK-4, MyD88, NEMO, or I?B? deficiency. Clin. Microbiol. Rev., 24, 490-7. ↗ Netea, MG., Wijmenga, C., O'Neill, LA. (2012) . Genetic variation in Toll-like receptors and disease susceptibility. Nat. Immunol., 13, 535-42. ↗ Zhang, SY., Abel, L., Casanova, JL. (2013) . Mendelian predisposition to herpes simplex encephalitis. (Picard C et al. 2003; Ku CL et al. 2007; Picard C et al. 2010; Picard C et al. 2011) . Leukocytes derived from IRAK4-deficient patients display a lack of production of inflammatory cytokines such as TNF alpha, IL-6 and IL-1 beta by whole blood or a lack of CD62 ligand (CD62L) shedding from granulocytes following activation with the most TLR agonists including those of TLR1/2 (Pam3CSK4), TLR2/6 (Pam2CSK4) and TLR4 (LPS) (Picard C et al. 2003; McDonald DR et al. 2006; Ku CL et al. 2007 ). However, LPS-induced TLR4-mediated production of some cytokines (IL8 and MIP-1beta) was reduced but not abolished (Ku CL et al. 2007 ). LPS-stimulated induction of type I IFN via
MyD88-IRAK4 independent signaling axis was normal or weakly affected suggesting that TLR4 could induce some responses in IRAK4 deficient patients (Yang K et al. 2005) .
Patients with AR IRAK4 deficiency were found to bear homozygous or compound heterozygous mutations in the IRAK4 gene (Picard C et al. 2003; Ku CL et al. 2007; McDonald DR et al. 2006 ). Here we describe selected mutations, that have been functionally characterized. Cell-based assay as well as in vitro protein-interaction analyses with IRAK4 variants showed that the loss-of-function of defective IRAK4 is caused by either loss of protein production (reported for IRAK4 Q293X and E402X) or an impaired inter- naling events, which are associated mostly with viral infections, although studies using patient-derived blood cells showed abolished cytokine production by peripheral blood mononuclear cells (PBMCs) and lack of CD62 ligand (CD62L) shedding from granulocytes in response to TLR7-9 agonists (McDonald DR et al. 2006; von Bernuth H et al. 2006; Ku CL et al. 2007 ). In addition to the TLR-NFkB signaling axis, endosomic TLR7-9 activates IFN-alpha/beta and IFN-gamma responses and these are also impaired in IRAK4deficient PBMC (Yang K et al. 2005) . Nevertheless, IFN-alpha/beta and -gamma production in IRAK-4-deficient blood cells in response to 9 of 11 viruses was normal or weakly affected, suggesting that IRAK-4deficient patients may control viral infections by TLR7-9-independent production of IFNs such as IRAK4independent antiviral RIGI and MDA5 pathways (Yang K et al. 2005) . So it is not yet possible to annotate a definitive molecular pathway between IRAK-4 deficiency and changes in TLR7-9 signaling.
Yamamoto, T., Tsutsumi, N., Tochio, H., Ohnishi, H., Kubota, K., Kato, Z. et al. (2014) . Leukocytes derived from IRAK4-deficient patients display a lack of production of inflammatory cytokines such as TNF alpha, IL-6 and IL-1beta or a lack of CD62 ligand (CD62L) shedding from granulocytes following activation with flagellin, the TLR5 agonist (Picard C et al. 2003; McDonald DR et al. 2006; Ku CL et al. 2007 ). Patients with AR IRAK4 deficiency were found to bear homozygous or compound heterozygous mutations in the IRAK4
gene (Picard C et al. 2003; Ku CL et al. 2007; McDonald DR et al. 2006 ). Here we describe selective mutations, that have been functionally characterized. Cell-based assays as well as in vitro protein-interaction analyses with IRAK4 variants showed that the loss-of-function of defective IRAK4 can be caused by either an abolished protein production as a result of nonsense mutations (e.g.,Q293X and E402X) or an impaired interaction with MyD88 due to missense mutations (e.g., R12C) (Ku CL et al. 2007; Yamamoto T et al. 2014 ).
IRAK4 mediates immune responses downstream of all TLRs except for TLR3. Besides defective TLR5 sig-naling, the Reactome module describes the impact of functional deficiency of IRAK4 on TLR2/4 signaling pathways. We did not include defective TLR7, TLR8 and TLR9 signaling events, which are stimulated by nucleic acids upon viral infections, although studies using patients-derived blood cells have showed abolished cytokines production by peripheral blood mononuclear cells (PBMCs) and lack of CD62 ligand (CD62L) shedding from granulocytes in response to TLR7-9 agonists, i.e.,3M-13 (TLR7), 3M-2 (TLR8), R848 (TLR7 and 8) and CpG (TLR9) (McDonald DR et al. 2006; von Bernuth H et al. 2006; Ku CL et al. 2007 ). In addition to TLR-NFkB signaling axis the endosomic TLR7-9 activate IFN-alpha/beta and IFNgamma responses, which have been also impaired in IRAK4-deficient PBMC (Yang K et al. 2005 ).
However, IFN-alpha/beta and IFN-gamma production in response to 9 of 11 viruses tested was normal or weakly affected in IRAK-4-deficient blood cells, suggesting that IRAK-4-deficient patients may control viral infections by TLR7-9-independent production of IFNs (Yang K et al. 2005) . So it is not yet possible to annotate a definitive molecular pathway between IRAK-4 deficiency and changes in TLR7-9 signaling.
Yamamoto, T., Tsutsumi, N., Tochio, H., Ohnishi, H., Kubota, K., Kato, Z. et al. (2014) . George J et al. 2011; Nagpal K et al. 2011; Yamamoto T et al. 2014 Functional assessment of MyD88 deficiency revealed that cytokine responses were abolished in patientderived blood cells upon stimulation with bacterial flagellin, which is recognized by TLR5 (von Bernuth et al. 2008 ). An NFkB luciferase reporter gene assay using human embryonic kidney 293 (HEK293T) cells showed that MyD88 variants, S34Y, E52del, E53X, L93P, R98C, and R196C, were compromised in the ability to enhance NFkB activation (Yamamoto T et al. 2014) . The molecular basis for the observed functional effects (reported for selected mutations) probably faulty Myddosome formation due to impaired MyD88 oligomerization and/or interaction with IRAK4 (George J et al. 2011; Nagpal K et al. 2011; Yamamoto T et al. 2014 (Bsibsi M et al. 2002) . TLR3 activity in neurons and glial cells was found to be critical for controlling herpes simplex virus type 1 (HSV-1) infection in CNS (Lafaille FG et al. 2012) . Children with inborn errors of TLR3-mediated immunity are prone to HSV-1 encephalitis (HSE), a rare life-threatening complication during HSV-1 infection (Casrouge A et al. 2006; Perez de Diego R et al. 2010; Zhang SY et al. 2007; Herman M et al. 2012; Lafaille FG et al. 2012 ). The functional defect in HSE patients with TLR3 deficiency is probably due to impaired induction of type I and III interferon (IFN) by cells of the CNS, which appears to be uniquely dependent upon TLR3 for protection against HSV1 (Zhang SY et al. 2007; Guo Y et al. 2011; Lafaille FG et al. 2012) . Importantly, blood cells in the periphery produce normal amounts of interferons, even in TLR3-deficient patients, which perhaps can be explained by RIGI or MDA5-mediated antiviral responses.
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UNC93B1 deficiency -HSE ↗ Location: Diseases associated with the TLR signaling cascade
Stable identifier: R-HSA-5602415
Diseases: primary immunodeficiency disease UNC93B1 is an endoplasmic reticulum protein with 12 membrane-spanning domains. Signaling cascades of nucleotide-sensing endosomal toll like receptors (TLR3 and TLR7-9) depends on functional UNC93B1, which is thought to deliver these TLRs from the ER to the endosome where they recognize specific pathogenic patterns and initiate host immune responses.
UNC93B deficiency has been implicated in the increased susceptibility to herpes simplex virus type 1 (HSV1) encephalitis (HSE), a rare complication during HSV-1 infection of the central nervous system (CNS) (Casrouge A et al. 2006 ). Patients-derived UNC96B1-deficient fibroblasts showed an impaired production of IFN-beta and -gamma following stimulation with TLR3 agonist poly(I:C) (Casrouge A et al. 2006 ). These cells were also more susceptible to HSV1 infection, showing rapid viral replication together with high mortality rates. Furthermore, pluripotent stem cells (iPSC) derived from HSE patient dermal fibroblasts were differentiated into populations of neural stem cells (NSC), neurons, astrocytes and oligodendrocytes (Lafaille FG et al. 2012) . The impaired induction of IFN beta and gamma was observed in all tested CNS cells upon stimulation with poly(I:C). However, HSV1 infection selectively affected type I and III IFN production in UNC93B1-deficient neurons and oligodendrocytes (Lafaille FG et al. 2012) . Thus, impaired TLR3-mediated UNC93B-dependent type I and III IFN production in respose to HSV1 infection in CNS, in neurons and oligodendrocytes in particular, may underline the pathogenesis of HSE in patients with UNC93B1 deficiency (Casrouge A et al. 2006; Lafaille FG et al. 2012) .
Defective UNC93B1 also impairs the TLR7, TLR8 and TLR9 signaling pathways. Peripheral blood mononuclear cells (PBMCs) from UNC93B-deficient patients did not respond to the stimulation of TLR7, TLR8, or TLR9, in terms of the production of type I and III interferons, and other cytokines tested (Casrouge A et al. 2006) . Moreover, no inducible CD62L shedding on granulocytes was detected after stimulation of whole blood cells derived from UNC93B-deficients patients with R-848 (agonist of TLR7 and TLR8) (von Bernuth H. et al. 2008 ). However, no clinical condition has been so far associated with impaired TLR7, TLR8, TLR9 due to UNC93B1 deficiency so this defect is not annotated here. 
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